Leadership

Prof John Mattick AO FAA FTSE FAHMS

Executive Director

Prof John MattickJohn Mattick was appointed Executive Director in 2012. He has a distinguished career in molecular biology, most recently as an NHMRC Australia Fellow and Director of the Institute for Molecular Bioscience, University of Queensland. He was awarded the 2011 IUBMB (International Union of Biochemistry and Molecular Biology Medal, the 2012 HUGO (Human Genome Organisation) Chen Medal, membership of the European Molecular Biology Organisation and Fellowship of the Australian Academy of Science, the Australian Academy of Technology & Engineering and the Australian Academy of Health & Medical Sciences.

John Mattick has recently accepted a prestigious new position as the inaugural Chief Executive Officer at Genomics England, the world’s largest clinical genomics initiative. Garvan’s current Deputy Director, Chris Goodnow, will succeed John as Executive Director.

Prof Chris Goodnow FAA FRS

Deputy Director 

Prof Chris GoodnowChris Goodnow is an internationally renowned immunologist. He joined Garvan in 2015. Chris has an extensive background on the faculty of Stanford University and the Australian National University, and in biotechnology start-up companies. He is best known for integrating molecular genetics and genomics with immunology, for which he received numerous awards and election to the Australian Academy of Science, the UK Royal Society, and the US National Academy of Science.

Chris Goodnow has recently accepted the position of Executive Director of Garvan. He will commence his Directorship in 2018, following John Mattick’s departure.  

Dr Marie Dziadek

Chief Scientific Officer

Dr Marie DziadekMarie Dziadek joined Garvan in 2012. She has extensive experience as a biomedical research leader and manager, having a background in cell and developmental biology, molecular genetics and cancer research.  After completing her DPhil from the University of Oxford she worked in the USA, Canada, and Germany before taking senior positions in medical research institutes and universities in Australia and New Zealand, including the University of Melbourne and the University of Auckland.

Kate Gunn

Chief Operating Officer

Kate-Gunn.jpgMs Kate Gunn joined Garvan in March 2018. Kate has 25 years of business experience and was most recently the Chief Operating Officer of the ARC Centre of Excellence for All-sky Astrophysics (CAASTRO) at Sydney University. She is also the Founder and Director of Balance! Healthcare. Balance! Healthcare is a leader in multi-disciplinary integrated primary healthcare, and has practices in NSW and QLD. In 2015, Kate won a scholarship from Chief Executive Women and the Women’s Leadership Institute to attend the Women’s Leadership Program, Harvard Business School, and in 2012 she was named as one of the inaugural 100 Women of Influence in Australia (by Westpac and the Australian Financial Review).

 

Contact for senior executives: 

Gabriella O'Neil – Executive Administrator
g.oneil@garvan.org.au 
tel: +61 (0) 2 9295 8120 


Board of directors

The Garvan Institute of Medical Research is an autonomous, non-profit research institute incorporated by Act of NSW Parliament. Read more about the history of the Garvan Institute.

The Garvan Institute Board determines policy and controls the Institute's affairs. The board meets quarterly and comprises 15 members (including the Executive Director), nominated by Garvan's stakeholders and appointed by the Governor of New South Wales.

John Schubert AO - Chair

John Schubert

Nominated by the Trustees of St Vincent's Hospital

Dr Schubert is Chairman of the Garvan Institute of Medical Research, Chairman of the Great Barrier Reef Foundation, and a director of the Garvan Research Foundation Board.

He has held positions as Chairman of the Commonwealth Bank of Australia, non-executive director of BHP Billiton Limited, BHP Billiton Plc, and Qantas Airways Limited, Chief Executive Officer of Pioneer International Limited, Chairman of WorleyParsons Limited and G2 Therapies Ltd, Chairman and MD of Esso Australia Ltd, and non-executive director of Hanson Plc.

Geoff Dixon

Geoff Dixon

Nominated by the Garvan Research Foundation

Mr Dixon was the chair of the Garvan Research Foundation until December 2017. He sits on the boards of Crown Resorts Limited, Adslot Limited and the Museum of Contemporary Art Australia, and is an Ambassador to the Australian Indigenous Education Foundation.

He has worked in the media, mining and aviation industries, and was Chief Executive of Qantas Airways from 2001 to 2008 and Chairman of Tourism Australia from 2009 to 2015.

Annabelle Bennett AO SC

Annabelle Bennett

Nominated by the Trustees of St Vincent's Hospital

The Hon Dr Annabelle Bennett AO SC was until recently a Judge of the Federal Court of Australia. She is presently Chancellor of Bond University, President of the Anti-Discrimination Board of NSW, Chair of Landservices SA, Arbitrator with the Court of Arbitration for Sport, and on the Advisory Council for Questacon.

Dr Bennett has extensive knowledge and experience in intellectual property arising from her position as a Judge, as a senior counsel specialising in Intellectual Property and as President of the Copyright Tribunal.

Annette Cunliffe RSC

Annette Cunliffe

Nominated by the Sisters of Charity

Sister Annette was the Sisters of Charity Congregational Leader. She has been President of the Conference of Leaders of Religious Institutes, President of Catholic Religious Australia, Inaugural Chair of the Stewardship Board of Catholic Health Australia, and a senior lecturer at the Australian Catholic University.

She is one of two executive officers of the National Committee for Professional Standards of the Catholic Church in Australia.

Stephen Johns 

Stephen Johns

Nominated by the Garvan Research Foundation

Mr Johns is Chairman of Brambles Limited and non-executive director of Goodman Group. He is a former chairman and non-executive director of Leighton Holdings Limited and Spark Infrastructure Group, and former executive and non-executive director of Westfield Group.

He has a Bachelor of Economics degree from the University of Sydney and is a Fellow of the Institute of Chartered Accountants in Australia and the Institute of Company Directors.

Anne Keating

Anne Keating

Nominated by the NSW Minister for Health

Ms Keating is a director of Goodman Group Ltd, Reva medical Inc and GI Dynamics Inc. She is also Chairman of Houlihan Lokey, Australia, an investment bank, and is a governor of the Cerebral Palsy Research Foundation.

She has served on many public company boards and was an inaugural director of the Victor Chang Cardiac Research Institute.

Thomas John (Jack) Martin  AO FAA FRS

Thomas John (Jack) Martin

Nominated by the Federal Minister for Health

Emeritus Professor Martin is a John Holt Fellow, St Vincent’s Institute of Medical Research and Emeritus Professor of Medicine, University of
Melbourne. He was previously the Director of St Vincent’s Institute of Medical Research and the Chairman of the University of Melbourne Department of Medicine.

A Fellow of the Royal Society and of the Australian Academy of Science, he was also President of the International Bone and Mineral Society.

John Mattick AO FAA

John Mattick

Nominated by the Garvan Board of Directors

Professor Mattick is the Garvan Institute Executive Director and Conjoint Professor at UNSW Sydney / St Vincent's Hospital Clinical School. Previously he was foundation Professor of Molecular Biology and Director of the Institute for Molecular Bioscience, University of Queensland.

His many awards include the Australian Government Centenary Medal and the Human Genome Organisation’s Chen Award for Distinguished Contributions to Human Genomic and Genetic Research.

Paul Kelly

Paul Kelly

Nominated by the Trustees of St Vincent's Hospital

Dr Kelly is a founding partner of One-Ventures and serves as a member of the Investment Committee and Risk Management Committee and is Managing Director of the Fund Manager. An Australian physician, serial entrepreneur and experienced biotechnology and life sciences executive, he currently has over 30 years experience in clinical medicine and medical science and 20 years experience in commercialising life science related technologies in Australia, Europe and North America.

Helen Nugent AO

Helen Nugent

Nominated by the NSW Minister for Health

Dr Nugent is the Chairman of the National Disability Insurance Agency, Ausgrid, and Australian Rail Track Corporation and a non-executive director of Insurance Australia Group Limited. She has been the Chairman of Veda Group, Funds SA, Swiss Re (Australia) and Sydney Airport and a non-executive director of Macquarie Group, Origin Energy Limited, Mercantile Mutual and the State Bank of NSW, among others. She is an Officer of the Order of Australia and a recipient of the Australian Government Centenary Medal.

Patricia O'Rourke

Patricia O'RourkeNominated by the Sisters of Charity

Professor O’Rourke is the CEO of St Vincent’s Health Australia’s Public Hospitals Division. She also serves on the boards of St Vincent's Institute of Medical Research.

She is a graduate of the Australian Institute of Company Directors and a member of the Harvard Business Club of Australia.

 

Rodney Phillips

Rodney Phillips

Nominated by UNSW Sydney

Professor Phillips, Dean of UNSW Medicine, is an immunologist whose research impacted the world’s understanding of HIV/AIDS and other infectious diseases.

He described, for the first time, how HIV evades the body’s immune defences. Previously, Professor Phillips was Vice-Dean of Medical Sciences at Oxford University and Director of the Peter Medawar Building for Pathogen Research.

Anthony Schembri

Anthony Schembri

Nominated by the Sisters of Charity

A/Professor Schembri, CEO of St Vincent’s Heath Network, holds academic appointments with the St Vincent’s Clinical Schools, of UNSW and Australian Catholic University.

He is a director of the Central and Eastern Sydney Primary Health Network, St Vincent’s Curran Foundation, co-chair of the Nursing Research Institute and a trustee of the Peter Duncan Neurosciences Unit.

Russell Scrimshaw

Russell Scrimshaw

Nominated by the Federal Minister for Health

Mr Scrimshaw is the Garvan Research Foundation Board Chair. He is also Non-Executive Chairman of Sirius Minerals Plc and the Executive Chairman of Torrus Capital P/L, the Australian Philanthropic Fund, the Scrimshaw Foundation and Scrimshaw Nominees P/L. Previously, he held executive positions at Fortescue Metals Group Ltd (FMG), Commonwealth Bank, Optus and IBM. He was also a non-executive Board Director for Genome.One, Commonwealth Properties Ltd, EDS Australia, Mobilesoft Ltd, Telecom New Zealand Australia Pty Ltd, and Athletics Australia.

Jillian Segal AM

Jillian Segal

Nominated by UNSW Sydney

Ms Segal is the Deputy Chancellor UNSW Sydney, Chairman of AICC (NSW) and the General Sir John Monash Foundation, a Trustee of the Sydney Opera House, and a director of the Grattan Institute.

She has been a senior regulator, lawyer and a director of other listed and Government organisations.